Evaluation of the CK-II Inhibitor Silmitasertib and the CDKs Inhibitor Dinaciclib in Pancreatic ductal Adenocarcinoma Cell Lines and the Relationship between Effect and genetic Background
ONCOLOGY RESEARCH AND TREATMENT(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要